Psoriasis

JNJ-2113 met primary endpoints in the FRONTIER 1 clinical trial.

Linda Stein Gold, MD, and Jennifer Soung, MD, discuss available nonsteroidal treatment options for plaque psoriasis in this DermView series recap.

Aaron Farberg, MD, and Jeffrey Crowley, MD, take a closer look at the management and treatment of generalized pustular psoriasis.

Linda Stein Gold, MD, clears up confusion regarding various treatment options for patients with mild to moderate forms of the disease.

An expert dermatologist reviews generalized pustular psoriasis in 2 patients and how he would approach treatment and management.

Over the last few decades, genetic research has opened doors to improve the treatment of immune-mediated conditions like psoriasis, but there are still questions about how these diseases are triggered at the cellular level.

Highly effective medications for severe disease are expensive and administered invasively, while the development of treatments for milder disease has lagged, a new review on psoriasis clinical trials concludes.

The long-believed causal association between inflammatory bowel disease and both psoriasis and psoriatic arthritis has been recently confirmed.

Boni E. Elewski, MD, shares her management pearls of how to treat difficult nail psoriasis and onychomycosis at the 2023 Winter Clinical Hawaii Dermatology Conference.

The year-long study gives insight to the treatment’s efficacy and safety of durability.

Patients with psoriasis were more likely to receive emergency food from churches, food banks, or soup kitchens.

Union therapeutics is also developing the drug for treatment of atopic dermatitis and hidradenitis suppurativa.

New pathways of care are needed to improve health care spending.

Patients with psoriasis seem to suffer more in the wintertime when flare-ups are much more common.

More drugs and treatment options continue to be explored, and in 2022, there were some exciting advancements in these areas for dermatologists treating psoriasis.

Click here to answer this week's poll.

A variety of topicals and biologics are now available to treat children affected by this challenging condition.

Patient enrollment is now open for the study conducted by late-stage biopharmaceutical company, Soligenix.

Arcutis Biotherapeutics' indication expansion is based on data from MUSE studies.

A biologic from Germany offers a new treatment option for a number of dermatologic conditions.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, discuss study limitations regarding health records in generalized pustular psoriasis and how the number of flares could be underestimated.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, discuss the importance of investigating the data on generalized pustular psoriasis, comorbidities of the disease, and commonly used treatments.

Experts in dermatology review data on various treatment interventions before, during, and after generalized pustular psoriasis flare episodes.

Recent review explores the difficulties of treating pediatric psoriasis.

New research examined brain structure and connectivity in patients with psoriasis.

Arcutis Biotherapeutics announced new positive data involving itch and itch-related sleep loss in adults with plaque psoriasis.

Drs Mark G. Lebwohl and Alice B. Gottlieb discuss future expectations in the treatment of plaque psoriasis.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, examine the results of a study of generalized pustular psoriasis, discussing flares and common signs and symptoms.

Aaron S. Farberg, MD, and Jeffrey Crowley, MD, review the demographics of people with generalized pustular psoriasis including age, race, and comorbidities.